Lilly (Eli)

Lilly (Eli) (LLY) is a publicly traded company in the Health Care sector, specifically within the Pharmaceuticals industry. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

The company reports trailing twelve-month revenue of $19.80B and net income of $7.40B.

Key metrics include a return on equity of 23.7%.

Investors tracking LLY can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.